By Ludwig Burger FRANKFURT (Reuters) – Germany’s Merck KGaA on Thursday warned that adjusted operating earnings could decline by as much as 10% this year as the outlook for its specialty c[...]
Read moreHealth
Martin Shkreli-founded drug company files for bankruptcy
By Dietrich Knauth NEW YORK (Reuters) – Vyera Pharmaceuticals, which previously settled price-fixing charges that resulted in founder Martin Shkreli being banned from the pharmaceutical industry[...]
Read moreSyneos taken private for $4.46 billion by investment consortium
(Reuters) -An investment consortium, comprising of Elliott Investment Management, Patient Square Capital and Veritas Capital, has agreed to take Syneos Health Inc private for $4.46 billion, the contra[...]
Read moreZealand, Boehringer’s drug meets main weight-loss goal in mid-stage trial
By Ludwig Burger FRANKFURT (Reuters) – Zealand Pharma and partner Boehringer Ingelheim said their experimental obesity drug achieved up to 14.9% weight loss after 46 weeks in a mid-stage trial,[...]
Read moreChinese company earnings reveal lopsided economic recovery
By Summer Zhen HONG KONG (Reuters) – People in China splashed out on dining, travel and luxury goods after emerging from three years of pandemic restrictions but are still not spending freely on[...]
Read moreNovavax forecasts higher-than-expected revenue; shares surge
By Bhanvi Satija and Michael Erman (Reuters) -COVID-19 vaccine maker Novavax Inc on Tuesday forecast much higher 2023 revenue than Wall Street expected and announced plans to cut a quarter of its work[...]
Read moreCigna’s health insurance strength drives profit forecast raise
By Leroy Leo and Khushi Mandowara (Reuters) -Cigna Group on Friday raised its annual profit forecast after lower medical costs at the company’s health insurance business helped it beat estimates[...]
Read moreFlying high on obesity success, Novo’s appetite for deals grows
By Natalie Grover LONDON (Reuters) – Buoyed by the success of its diabetes and obesity drugs, Novo Nordisk is on the prowl for partnerships and deals to beef up its pipeline, a senior company ex[...]
Read moreKroger to pay $68 million to settle West Virginia opioid claims
By Brendan Pierson (Reuters) -The Kroger Co has agreed to pay West Virginia $68 million to settle claims that it fueled the opioid epidemic through lax oversight of its pill sales, bringing the state[...]
Read more